CT
Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.
About
Casma Therapeutics is a biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. They leverage a deep understanding of cellular and molecular mechanisms to create innovative treatments. The company's approach aims to address the underlying causes of these conditions, offering new hope for patients with unmet medical needs.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
58Traction
40Team
30Visibility
2Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Casma Therapeutics do?
Casma Therapeutics is a biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. They leverage a deep understanding of cellular and molecular mechanisms to create innovative treatments. The company's approach aims to address the underlying causes of these conditions, offering new hope for patients with unmet medical needs.
How much funding has Casma Therapeutics raised?
Casma Therapeutics has raised a total of $155M in funding. The most recent round on record is Series C.
Where is Casma Therapeutics headquartered?
Casma Therapeutics is headquartered in Cambridge, United States.
When was Casma Therapeutics founded?
Casma Therapeutics was founded in 2021.
What industry does Casma Therapeutics operate in?
Casma Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Autophagy.
Similar Startups